Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection

Oluwatoyin Falusi, Audrey L. French, Eric C. Seaberg, Phyllis C. Tien, D. Heather Watts, Howard Minkoff, Eva Piessens, Andrea Kovacs, Kathryn Anastos, Mardge H. Cohen

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

We assessed the prevalence and predictors of latent Toxoplasma infection in a large group of human immunodeficiency virus (HIV)-infected and HIV-uninfected at-risk US women. The prevalence of latent Toxoplasma infection was 15% (380 of 2525 persons) and did not differ by HIV infection status. HIV-infected women aged ≥ 50 years and those born outside of the United States were more likely to have latent Toxoplasma infection, with prevalences of 32% and 41%, respectively.

Original languageEnglish (US)
Pages (from-to)1414-1417
Number of pages4
JournalClinical Infectious Diseases
Volume35
Issue number11
DOIs
StatePublished - Dec 1 2002

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection'. Together they form a unique fingerprint.

  • Cite this

    Falusi, O., French, A. L., Seaberg, E. C., Tien, P. C., Watts, D. H., Minkoff, H., Piessens, E., Kovacs, A., Anastos, K., & Cohen, M. H. (2002). Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clinical Infectious Diseases, 35(11), 1414-1417. https://doi.org/10.1086/344462